Investors must take note of Viracta Therapeutics Inc’s (VIRX) performance last week, which was -11.66%.
Viracta Therapeutics Inc (NASDAQ: VIRX) kicked off on Friday, down -2.38% from the previous trading day, before settling in for the closing price of $0.16.